{"id":"https://openalex.org/W2603969996","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.3001","title":"SU11248, a multi-targeted tyrosine kinase inhibitor, can overcome imatinib (IM) resistance caused by diverse genomic mechanisms in patients (pts) with metastatic gastrointestinal stromal tumor (GIST)","display_name":"SU11248, a multi-targeted tyrosine kinase inhibitor, can overcome imatinib (IM) resistance caused by diverse genomic mechanisms in patients (pts) with metastatic gastrointestinal stromal tumor (GIST)","publication_year":2004,"publication_date":"2004-07-15","ids":{"openalex":"https://openalex.org/W2603969996","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.3001","mag":"2603969996"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2004.22.14_suppl.3001","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.3001","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.3001","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060580923","display_name":"George D. Demetri","orcid":"https://orcid.org/0000-0002-0045-4809","observed_orcids":["https://orcid.org/0000-0002-0045-4809"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. D. Demetri","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Brigham and Women's Hospital, Boston, MA; Pfizer, Inc, La Jolla, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; Oregon Health and Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Brigham and Women's Hospital, Boston, MA; Pfizer, Inc, La Jolla, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; Oregon Health and Science University, Portland, OR","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I1334819555","https://openalex.org/I165690674","https://openalex.org/I180857899","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078038970","display_name":"Jayesh Desai","orcid":"https://orcid.org/0000-0003-4246-9344","observed_orcids":["https://orcid.org/0000-0003-4246-9344"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Desai","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Brigham and Women's Hospital, Boston, MA; Pfizer, Inc, La Jolla, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; Oregon Health and Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Brigham and Women's Hospital, Boston, MA; Pfizer, Inc, La Jolla, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; Oregon Health and Science University, Portland, OR","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I1334819555","https://openalex.org/I165690674","https://openalex.org/I180857899","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110474862","display_name":"Jonathan A. Fletcher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. A. Fletcher","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Brigham and Women's Hospital, Boston, MA; Pfizer, Inc, La Jolla, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; Oregon Health and Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Brigham and Women's Hospital, Boston, MA; Pfizer, Inc, La Jolla, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; Oregon Health and Science University, Portland, OR","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I1334819555","https://openalex.org/I165690674","https://openalex.org/I180857899","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042802176","display_name":"Jeffrey A. Morgan","orcid":"https://orcid.org/0009-0006-6476-161X","observed_orcids":["https://orcid.org/0009-0006-6476-161X"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. A. Morgan","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Brigham and Women's Hospital, Boston, MA; Pfizer, Inc, La Jolla, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; Oregon Health and Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Brigham and Women's Hospital, Boston, MA; Pfizer, Inc, La Jolla, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; Oregon Health and Science University, Portland, OR","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I1334819555","https://openalex.org/I165690674","https://openalex.org/I180857899","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050651568","display_name":"Christopher D.\ufffdM. Fletcher","orcid":"https://orcid.org/0000-0002-8053-9537","observed_orcids":["https://orcid.org/0000-0002-8053-9537"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. D. M. Fletcher","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Brigham and Women's Hospital, Boston, MA; Pfizer, Inc, La Jolla, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; Oregon Health and Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Brigham and Women's Hospital, Boston, MA; Pfizer, Inc, La Jolla, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; Oregon Health and Science University, Portland, OR","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I1334819555","https://openalex.org/I165690674","https://openalex.org/I180857899","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057715561","display_name":"A. Kazanovicz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Kazanovicz","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Brigham and Women's Hospital, Boston, MA; Pfizer, Inc, La Jolla, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; Oregon Health and Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Brigham and Women's Hospital, Boston, MA; Pfizer, Inc, La Jolla, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; Oregon Health and Science University, Portland, OR","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I1334819555","https://openalex.org/I165690674","https://openalex.org/I180857899","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110310090","display_name":"A. Van Den Abbeele","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Van Den Abbeele","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Brigham and Women's Hospital, Boston, MA; Pfizer, Inc, La Jolla, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; Oregon Health and Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Brigham and Women's Hospital, Boston, MA; Pfizer, Inc, La Jolla, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; Oregon Health and Science University, Portland, OR","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I1334819555","https://openalex.org/I165690674","https://openalex.org/I180857899","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051363304","display_name":"Charles M. Baum","orcid":"https://orcid.org/0000-0003-4481-1211","observed_orcids":["https://orcid.org/0000-0003-4481-1211"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Baum","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Brigham and Women's Hospital, Boston, MA; Pfizer, Inc, La Jolla, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; Oregon Health and Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Brigham and Women's Hospital, Boston, MA; Pfizer, Inc, La Jolla, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; Oregon Health and Science University, Portland, OR","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I1334819555","https://openalex.org/I165690674","https://openalex.org/I180857899","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068677359","display_name":"Robert G. Maki","orcid":"https://orcid.org/0000-0002-9853-2528","observed_orcids":["https://orcid.org/0000-0002-9853-2528"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Maki","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Brigham and Women's Hospital, Boston, MA; Pfizer, Inc, La Jolla, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; Oregon Health and Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Brigham and Women's Hospital, Boston, MA; Pfizer, Inc, La Jolla, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; Oregon Health and Science University, Portland, OR","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I1334819555","https://openalex.org/I165690674","https://openalex.org/I180857899","https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091057405","display_name":"Michael Charles Heinrich","orcid":"https://orcid.org/0000-0003-3790-0478","observed_orcids":["https://orcid.org/0000-0003-3790-0478"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. C. Heinrich","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Brigham and Women's Hospital, Boston, MA; Pfizer, Inc, La Jolla, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; Oregon Health and Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Brigham and Women's Hospital, Boston, MA; Pfizer, Inc, La Jolla, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; Oregon Health and Science University, Portland, OR","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I1334819555","https://openalex.org/I165690674","https://openalex.org/I180857899","https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":107,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":"14_suppl","first_page":"3001","last_page":"3001"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11485","display_name":"Gastrointestinal Tumor Research and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11485","display_name":"Gastrointestinal Tumor Research and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":0.9940000176429749},{"id":"https://openalex.org/keywords/imatinib-resistance","display_name":"imatinib resistance","score":0.9580000042915344},{"id":"https://openalex.org/keywords/gastrointestinal-stromal-tumor","display_name":"gastrointestinal stromal tumor","score":0.9639999866485596},{"id":"https://openalex.org/keywords/kit-mutations","display_name":"KIT mutations","score":0.6980000138282776},{"id":"https://openalex.org/keywords/pdgfra-mutation","display_name":"PDGFRA mutation","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.878000020980835},{"id":"https://openalex.org/keywords/kit-exon-11","display_name":"KIT exon 11","score":0.8769999742507935},{"id":"https://openalex.org/keywords/alternative-signaling-pathways","display_name":"alternative signaling pathways","score":0.7009999752044678},{"id":"https://openalex.org/keywords/metastatic-gist","display_name":"metastatic GIST","score":0.699999988079071}],"concepts":[{"id":"https://openalex.org/C2775922572","wikidata":"https://www.wikidata.org/wiki/Q83567","display_name":"GiST","level":3,"score":0.8008395433425903},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7566879987716675},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.685997724533081},{"id":"https://openalex.org/C37307934","wikidata":"https://www.wikidata.org/wiki/Q18030422","display_name":"PDGFRA","level":4,"score":0.624451220035553},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.6121525168418884},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.548089861869812},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.5273352861404419},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.48908573389053345},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.47451940178871155},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.4503921866416931},{"id":"https://openalex.org/C2777007597","wikidata":"https://www.wikidata.org/wiki/Q16869243","display_name":"Stromal tumor","level":3,"score":0.4357280135154724},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4047197103500366},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3786632716655731},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3194696307182312},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2535838484764099},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.2346775233745575},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.12252771854400635},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2004.22.14_suppl.3001","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.3001","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.3001","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"doi:10.1200/jco.2004.22.90140.3001","doi":"https://doi.org/10.1200/jco.2004.22.90140.3001","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.90140.3001","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2581960448","https://openalex.org/W2323304680","https://openalex.org/W2269193243","https://openalex.org/W1996537922","https://openalex.org/W2252961166","https://openalex.org/W2163973379","https://openalex.org/W1999106017","https://openalex.org/W2081016143","https://openalex.org/W1965871143","https://openalex.org/W2159360580"],"abstract_inverted_index":{"3001":[0],"Background:":[1],"Resistance":[2],"to":[3,46,63,86,225,237,259,281],"Imatinib":[4],"mesylate":[5],"(IM)":[6],"following":[7],"initial":[8],"tumor":[9,116],"regression":[10],"and":[11,53,94,99,123,207,267,277],"disease":[12,168,210],"control":[13,208],"in":[14,35,42,76,111,120,127,152,173,211,244,254,272],"GIST":[15,43,67,107,124,218,256,276],"is":[16],"increasingly":[17],"recognized":[18],"as":[19],"an":[20],"unmet":[21],"medical":[22],"need.":[23],"IM":[24],"resistance":[25,224],"can":[26,203],"be":[27],"correlated":[28],"with":[29,78,105,115,181,213,219,246],"the":[30,36,58,88,92,230,240,250,261,273],"appearance":[31],"of":[32,49,57,65,74,91,176,217,223,242,252,264,275],"secondary":[33,194],"mutations":[34,195],"KIT":[37,93,188,266],"or":[38,166,291,294],"PDGFRA":[39,95],"tyrosine":[40],"kinases":[41,61,96],"lesions":[44],"refractory":[45],"IM;":[47],"activation":[48],"alternative":[50],"signaling":[51,270],"pathways":[52,271],"different":[54,220],"structural":[55,262],"biology":[56,263],"new":[59],"mutant":[60],"contribute":[62],"emergence":[64],"IM-resistant":[66,80,247,255],"clones.":[68],"Methods:":[69],"Phase":[70],"I/II":[71],"clinical":[72,160],"trial":[73,236],"SU11248":[75,135,157,201,243,253],"pts":[77,104,122,212,245],"progressing":[79,179],"GIST.":[81,199,248],"Tumor":[82],"biopsies":[83],"were":[84],"obtained":[85],"define":[87,238],"mutational":[89,215],"status":[90],"by":[97,145,163],"dHPLC":[98],"sequencing":[100],"assays.":[101],"Results:":[102],"98":[103],"progressive":[106,209],"have":[108,279],"been":[109],"enrolled":[110],"this":[112],"ongoing":[113],"study;":[114],"response":[117,165],"data":[118,228],"available":[119],"48":[121],"genotype":[125],"determined":[126],"41.":[128],"The":[129],"phase":[130,234],"II":[131],"regimen":[132],"chosen":[133],"was":[134],"50":[136],"mg":[137],"orally":[138],"once":[139],"daily":[140],"for":[141,169,232,285],"4":[142],"weeks,":[143],"followed":[144],"a":[146,233],"2":[147],"week":[148],"period":[149],"off":[150],"drug":[151],"each":[153],"6":[154,171],"wk":[155],"cycle.":[156],"therapy":[158,202],"induced":[159],"benefit":[161],"(defined":[162],"objective":[164,205],"stable":[167],"\u2265":[170],"months)":[172],"26/48":[174],"(54%)":[175],"these":[177],"previously":[178],"pts,":[180],"6/48":[182],"(13%)":[183],"confirmed":[184],"partial":[185],"responses":[186,206],"(PR).":[187],"exon":[189],"9":[190],"mutants":[191],"had":[192],"fewer":[193],"than":[196],"Exon":[197],"11":[198],"Conclusions:":[200],"induce":[204],"several":[214],"variants":[216],"genomic":[221],"mechanisms":[222],"IM.":[226],"These":[227],"are":[229],"basis":[231],"III":[235],"further":[239],"activity":[241],"Understanding":[249],"efficacy":[251],"should":[257],"help":[258],"elucidate":[260],"PDGFRA,":[265],"other":[268,286],"aberrant":[269],"pathogenesis":[274],"may":[278],"relevance":[280],"molecularly":[282],"targeted":[283],"therapies":[284],"malignancies.":[287],"Author":[288],"Disclosure":[289],"Employment":[290],"Leadership":[292],"Consultant":[293],"Advisory":[295],"Stock":[296],"Ownership":[297],"Honoraria":[298],"Research":[299],"Funding":[300],"Expert":[301],"Testimony":[302],"Other":[303],"Remuneration":[304],"Pfizer":[305,307,308,310,311],"Novartis;":[306,309],"Oncology":[312]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2017-04-07T00:00:00"}